/NAYA

NAYA Stock - NAYA Biosciences, Inc.

Q: What is the analyst price target for NAYA?

Analyst price target information is not currently available for NAYA.

Q: What is NAYA's market cap?

Market capitalization information is not currently available for NAYA.

Healthcare|Medical - Devices|NASDAQ

$2.20+8.37%

+$0.17 (+8.37%) • Apr 25

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $2.42

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for NAYA

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2020

FY2021

FY2022

FY2023

FY2024

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta2.04

52W High$17.04

52W Low$1.38

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2024	FY2023	FY2022	FY2021	FY2020
Revenue	$6.53M	$3.02M	$822,196	$4.16M	$1.04M
Gross Profit	$2.87M	$1.09M	$-28,574	$4.02M	$948,526
Gross Margin	44.0%	36.0%	-3.5%	96.5%	91.4%
Operating Income	$-8,125,496	$-6,767,155	$-10,626,481	$-5,216,524	$-5,514,966
Net Income	$-9,095,838	$-8,034,612	$-10,892,511	$-6,654,940	$-8,347,316
Net Margin	-139.3%	-266.0%	-1324.8%	-160.0%	-804.7%
EPS	$-30.19	$-5.13	$-8.99	$-6.26	$-15.21

Company Overview

INVO Bioscience is a medical device company providing devices and products for infertility diagnosis. Its flagship product is INVOcell, a reproductive technology that allows fertilization and early embryo development to take place within the woman’s body.

Visit Website

Earnings History & Surprises

NAYA

Beat Rate

90%

Last 10 quarters

Avg Surprise

+38.1%

EPS vs Estimate

Beats / Misses

9/1

Last 12 quarters

Latest EPS

$-11.71

Q2 2025

EPS Surprise History

Q1 23

+97.3%

$-1.02vs$-38.40

Q2 23

+98.5%

$-0.76vs$-50.40

Q3 23

+97.0%

$-0.35vs$-11.88

Q4 23

+92.3%

$-0.80vs$-10.44

Q2 24

+78.1%

$-0.42vs$-1.92

Q3 24

+63.1%

$-0.62vs$-1.68

Q4 24

-366.7%

$-5.04vs$-1.08

Q2 25

+72.1%

$-11.71vs$-42.00

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q3 2025	Aug 12, 2025	—	—	—	—
Q2 2025	Apr 22, 2025	$-42.00	$-11.71	+72.1%	✓ BEAT
Q4 2024	Nov 19, 2024	$-1.08	$-5.04	-366.7%	✗ MISS
Q3 2024	Aug 14, 2024	$-1.68	$-0.62	+63.1%	✓ BEAT
Q2 2024	May 15, 2024	$-1.92	$-0.42	+78.1%	✓ BEAT
Q4 2023	Dec 31, 2023	$-10.44	$-0.80	+92.3%	✓ BEAT
Q3 2023	Sep 30, 2023	$-11.88	$-0.35	+97.0%	✓ BEAT
Q2 2023	Jun 30, 2023	$-50.40	$-0.76	+98.5%	✓ BEAT
Q1 2023	Mar 31, 2023	$-38.40	$-1.02	+97.3%	✓ BEAT
Q4 2022	Dec 31, 2022	$-45.60	$-1.14	+97.5%	✓ BEAT
Q3 2022	Sep 30, 2022	—	$-1.05	—	—
Q2 2022	Jun 30, 2022	$-2.40	$-1.16	+51.8%	✓ BEAT
Q1 2022	Mar 31, 2022	—	$-1.15	—	—
Q4 2021	Dec 31, 2021	—	$-0.06	—	—
Q3 2021	Sep 30, 2021	—	$-1.07	—	—
Q2 2021	Jun 30, 2021	—	$-0.87	—	—
Q1 2021	Mar 31, 2021	—	$-1.24	—	—
Q4 2020	Dec 31, 2020	—	$-3.00	—	—
Q3 2020	Sep 30, 2020	—	$-2.87	—	—
Q2 2020	Jun 30, 2020	—	$-1.34	—	—

Frequently Asked Questions about NAYA

What is NAYA's current stock price?

NAYA Biosciences, Inc. (NAYA) is currently trading at $2.20 per share. The stock has moved +8.37% today.

What is the analyst price target for NAYA?

No analyst price targets are currently available for this stock.

What sector is NAYA Biosciences, Inc. in?

NAYA Biosciences, Inc. operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the NASDAQ exchange.

What is NAYA's market cap?

NAYA Biosciences, Inc. has a market capitalization of $0.00 billion, making it a small-cap company.

Does NAYA pay dividends?

No, NAYA Biosciences, Inc. does not currently pay a dividend to shareholders.